Sushmi Dey / New Delhi Jul 30, 2012, 00:41 IST Drug makers Lupin and Novartis have entered into a marketing alliance under which Lupin would sell Novartis’ asthma drug, Onbrez, in India. The recently-launched product is a once-daily therapy used in the treatment of chronic obstructive pulmonary disease (COPD). BSE According to the agreement, Novartis would share a part of its revenue from the sales of the drug with Lupin, an industry source said. An email sent to both Novartis and Lupin did not e...

A new report, published today in PLoS One shows that RADARS(R) System Poison Center data can be used to predict methadone overdose trends in the U.S. The Centers for Disease Control and Prevention recently found that methadone is linked to 30 percent of prescription painkiller overdose deaths, mostly resulting from the use of methadone in pain management. However, national overdose mortality data takes more than three years to become available, leaving local and state health authorities without a c...